The pharmaceutical company AstraZeneca halted global trials of its coronavirus vaccine on Tuesday because of a serious and unexpected adverse reaction in a participant, the company said.
1 Comment
99th Monkey
13/9/2020 12:47:24 pm
(Natural News) It has finally been revealed that the participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trial who suffered a “serious adverse event,” causing a global shutdown of the company’s entire phase-three trial, developed a spinal inflammatory disorder known as transverse myelitis.
Reply
Leave a Reply. |
Crossroads blogThe random thoughts of 99th Monkey . . . an occasional rant and other reflections in the hall of mirrors. Archives
October 2023
Categories |